Rottendorf Pharma, a CDMO based in Germany, has chosen ValGenesis‘ validation lifecycle management system (VLMS) to digitize its corporate validation process.
 
Rottendorf Pharma specializes in developing, manufacturing and packaging formulations and analytical methods for oral solid dosage forms, providing services for pharmaceutical and biotechnology companies. 
 
Rottendorf Pharma selected ValGenesis VLMS to streamline and standardize processes According to the company, VLMS 5.0 offers an intuitive user interface and an innovative, technologically advanced solution for future enhancements.
 
“As a crucial player in Germany’s pharmaceutical supply chain, Rottendorf Pharma is poised for a manufacturing transformation with ValGenesis VLMS,” said Steve Reynolds, Chief Revenue Officer at ValGenesis. “Their selection of our digital validation platform aligns perfectly with their commitment to both quality and rapid drug delivery. This partnership exemplifies ValGenesis’ dedication to supporting the advanced needs of the CDMO industry.”
 
“After a thorough comparison of two software providers, we chose ValGenesis VLMS because it aligns perfectly with our needs, offering the specific functions and tools required to streamline and digitize our processes. The software’s advanced technology and clear roadmap for future innovation ensure that it will continue to deliver value and support our growth,” said Markus Krellmann, Head of Validation at Rottendorf Pharma.